Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Hologic, Inc. (HOLX) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell

September 30, 2008

ADVISORY, Sept. 30, 2008 (GLOBE NEWSWIRE) —

    What:  John W. Cumming, Chief Executive Officer of Hologic, Inc. (HOLX),  will preside over the Opening Bell.   Where:  NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio   When:  Wednesday, October 1, 2008 at 9:15 - 9:30 a.m. ET   Contact:  Fran Doria  (781) 999-7377   NASDAQ MarketSite:  Robert Madden  (646) 441-5045  Robert.Madden@NASDAQOMX.com 

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on Galaxy 28 C/9, downlink frequency 3880 horizontal. The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Robert Madden at (646) 441-5045.

Radio Feed:

An audio transmission of the opening bell is also available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Webcast:

A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm.

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Hologic, Inc. (HOLX):

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic’s core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies, with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. With its acquisition of Third Wave on July 24, 2008, the Company’s diagnostics segment now includes products that cover molecular diagnostic reagents for a variety of DNA and RNA analysis applications.

This news release was distributed by GlobeNewswire, www.globenewswire.com